Effects of optimized-SopungSunkiwon on memory impairment and enhancement

被引:13
作者
Choi, Jin Gyu [1 ,2 ]
Yang, Woong Mo [3 ]
Kang, Tong Ho [4 ]
Oh, Myung Sook [1 ,2 ]
机构
[1] Kyung Hee Univ, Coll Pharm, Dept Oriental Pharmaceut Sci, Seoul 130701, South Korea
[2] Kyung Hee Univ, Kyung Hee EW Pharmaceut Res Inst, Seoul 130701, South Korea
[3] Kyung Hee Univ, Coll Oriental Med, Dept Prescriptionol, Seoul 130701, South Korea
[4] Kyung Hee Univ, Coll Life Sci, Dept Oriental Med Mat & Proc, Yongin 446701, Gyeonggi Do, South Korea
关键词
OSS; Alzheimer's disease; Memory; Synapse; DIABETIC FATTY RATS; WON SP PREVENTS; ALZHEIMERS-DISEASE; CHOLINERGIC HYPOTHESIS; SCOPOLAMINE; NEURONS; MICE;
D O I
10.1016/j.neulet.2010.12.058
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Optimized-SopungSunkiwon (OSS) is a multi-herbal formula that contains six medicinal herbs from SopungSunkiwon, a traditional medicine used for neurodegenerative disorders. In this study, we investigated the anti-amnesic effects of OSS in a dementia model. Acetylcholinesterase (AChE) inhibition assay was performed to investigate the cholinergic antagonistic effect of OSS. In addition, a step-through passive-avoidance test was performed with scopolamine-induced memory impairment in mice, and immunohistochemistry was analyzed to investigate synaptic formation with synaptic proteins. OSS inhibited AChE activity, resulting in significant improvement of memory functions. In the passive-avoidance test, the latency time of OSS-treated mice was significantly longer than that of either the control or scopolamine-treated group. In the immunohistochemical analysis, synaptic proteins such as synaptophysin and PSD-95 were significantly increased in OSS-treated mice. These results demonstrate that OSS may affect impairment and enhancement of memory and increase synaptophysin and PSD-95 facilitating acetylcholine release and synaptic growth. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 20 条
[1]
THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[2]
Synapse Loss in Dementias [J].
Clare, Ryan ;
King, Victoria G. ;
Wirenfeldt, Martin ;
Vinters, Harry V. .
JOURNAL OF NEUROSCIENCE RESEARCH, 2010, 88 (10) :2083-2090
[3]
DEMENTIA - THE NEUROCHEMICAL BASIS OF PUTATIVE TRANSMITTER ORIENTATED THERAPY [J].
COURT, JA ;
PERRY, EK .
PHARMACOLOGY & THERAPEUTICS, 1991, 52 (03) :423-443
[4]
A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba -: Anticholinesterase and cognitive enhancing activities [J].
Das, A ;
Shanker, G ;
Nath, C ;
Pal, R ;
Singh, S ;
Singh, HK .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 73 (04) :893-900
[5]
DAVIES P, 1976, LANCET, V2, P1403
[6]
Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine [J].
Deiana, Serena ;
Harrington, Charles R. ;
Wischik, Claude M. ;
Riedel, Gernot .
PSYCHOPHARMACOLOGY, 2009, 202 (1-3) :53-65
[7]
Ebert U, 1998, EUR J CLIN INVEST, V28, P944
[8]
El-Hussein AE, 2000, SCIENCE, V290, P1364
[9]
Ellison D., 2004, Neuropathology: A reference text of CNS pathology
[10]
A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&